Search by Drug Name or NDC
NDC 41163-0374-85 Equaline migraine formula 250; 250; 65 mg/1; mg/1; mg/1 Details
Equaline migraine formula 250; 250; 65 mg/1; mg/1; mg/1
Equaline migraine formula is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by United Natural Foods, Inc. dba UNFI. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
NDC | 41163-0374 |
---|---|
Product ID | 41163-374_c8123dac-6bc5-4f29-9905-c792c9fc77e6 |
Associated GPIs | 64990003200350 |
GCN Sequence Number | 040186 |
GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
HIC3 | H3D |
HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
GCN | 10414 |
HICL Sequence Number | 001807 |
HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
Brand/Generic | Generic |
Proprietary Name | Equaline migraine formula |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Acetaminophen, Aspirin, Caffeine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 250; 250; 65 |
Active Ingredient Units | mg/1; mg/1; mg/1 |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Labeler Name | United Natural Foods, Inc. dba UNFI |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA075794 |
Listing Certified Through | 2024-12-31 |
Package
NDC 41163-0374-85 (41163037485)
NDC Package Code | 41163-374-85 |
---|---|
Billing NDC | 41163037485 |
Package | 250 TABLET, FILM COATED in 1 BOTTLE (41163-374-85) |
Marketing Start Date | 2004-09-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |